at CNBC.com (Jan 10, 2014)
Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA +0.7%). The firm says it's not concerned with recent headlines and believes organic growth estimates will prove conservative. The firm rates the shares at Outperform with a $12 price target.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at CNBC.com (Jul 30, 2013)
at MarketWatch.com (Jul 30, 2013)
at Fox Business (Jul 30, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs